Vimarsana
Biggest News Aggregation in the World

Page 37 - Icon Plc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Icon Plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Icon Plc Today - Breaking & Trending Today

Medical Affairs Outsourcing Market, 2027 - Vimarsana News

Medical Affairs Outsourcing Market, 2027

Medical Affairs Outsourcing Market, 2027 News provided by Share this article Share this article Medical Science Liaisons (MSLs) Segment to Grow at Highest CAGR During 2020-2027 Medical Affairs Outsourcing Market is expected to reach US$ 3,287.12 million by 2027 from US$ 1,415.00 million in 2019. It is estimated to grow at a CAGR of 11.2% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth. Factors such as increasing number of clinical trials and rising adoption of outsourcing activities coupled with increasing R&...

The Worldwide Virtual Clinical Trials Industry is Expected to Reach $10 Billion by 2026 - Vimarsana News

The Worldwide Virtual Clinical Trials Industry is Expected to Reach $10 Billion by 2026

The Worldwide Virtual Clinical Trials Industry is Expected to Reach $10 Billion by 2026 News provided by Share this article Share this article ResearchAndMarkets.com's offering. The Global Virtual Clinical Trials Market size is expected to reach $10 billion by 2026, rising at a market growth of 6.5% CAGR during the forecast period. Virtual Clinical Trials (VCTs) are also known as remote or decentralized trails, are a comparatively new but still underused technique of carrying out clinical research taking complete benefit of technologies like apps, online social interaction platforms, and ele...

Thermo Fisher to buy PPD for $17.4 billion as health care deals soar during the pandemic - Vimarsana News

Thermo Fisher to buy PPD for $17.4 billion as health care deals soar during the pandemic

Thermo Fisher is the biggest public company based in Massachusetts. Its acquisition of PPD represents a push into drug development and clinical trial services in the biotech and pharma industries.

Thermo to buy PPD for US$17.4 billion as health deals soar - Vimarsana News

Thermo to buy PPD for US$17.4 billion as health deals soar

Christine Poole's Top Picks: April 15, 2021 China's very bad bank: Inside the Huarong debt debacle David Fingold's Top Picks: April 14, 2021 Archegos ripples through banks' lucrative hedge fund business NFT fans want to crack the Da Vinci code Fat finger briefly trims US$4B off Barclays' market cap Canaccord prepared to raise offer for rival RF Capital, CEO says Tech leads stock decline from record; bonds drop Ontario pension manager plots real estate cut, credit growth Gordon Reid's Top Picks: April 13, 2021 China Huarong's worsening bond rout stokes market contagion Stocks, bonds rise with ...

Thermo Fisher Buys PPD for $17.4B, as Healthcare Deals Soar - Vimarsana News

Thermo Fisher Buys PPD for $17.4B, as Healthcare Deals Soar

Thermo Fisher Buys PPD for $17.4B, as Healthcare Deals Soar Related Stories April 8, 2021 April 1, 2021 April 1, 2021 Thermo Fisher Scientific Inc. has agreed to acquire PPD Inc., a provider of clinical and research services to the pharma and biotech industries, for $17.4 billion as healthcare deal making soars amid the pandemic. Thermo Fisher will pay $47.50 a share for PPD, according to a statement Thursday, and will assume about $3.5 billion of net debt. The price represents a premium of about 24% to the PPD closing price Tuesday, before reports of a possible deal. Companies like PPD that...